Ameriprise Financial Inc Enanta Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 328,311 shares of ENTA stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
328,311
Previous 29,938 996.64%
Holding current value
$2.06 Million
Previous $388,000 777.32%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.05 - $16.54 $3 Million - $4.94 Million
298,373 Added 996.64%
328,311 $3.4 Million
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $22,117 - $32,933
-1,935 Reduced 6.07%
29,938 $388,000
Q1 2024

May 15, 2024
SELL
$10.08 - $17.46 $622,228 - $1.08 Million
-61,729 Reduced 65.95%
31,873 $556,000
Q4 2023

Feb 14, 2024
BUY
$8.18 - $10.78 $401,646 - $529,308
49,101 Added 110.34%
93,602 $880,000
Q3 2023

Nov 14, 2023
SELL
$11.09 - $22.13 $769,912 - $1.54 Million
-69,424 Reduced 60.94%
44,501 $497,000
Q2 2023

Aug 14, 2023
SELL
$20.68 - $39.85 $59,847 - $115,325
-2,894 Reduced 2.48%
113,925 $2.44 Million
Q1 2023

May 15, 2023
SELL
$38.82 - $54.59 $57,104 - $80,301
-1,471 Reduced 1.24%
116,819 $4.72 Million
Q4 2022

Feb 14, 2023
SELL
$40.77 - $53.73 $134,337 - $177,040
-3,295 Reduced 2.71%
118,290 $5.5 Million
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $1.19 Million - $1.76 Million
24,712 Added 25.51%
121,585 $6.31 Million
Q2 2022

Aug 15, 2022
SELL
$38.13 - $76.93 $196,026 - $395,497
-5,141 Reduced 5.04%
96,873 $4.58 Million
Q1 2022

May 16, 2022
BUY
$56.06 - $74.11 $33,187 - $43,873
592 Added 0.58%
102,014 $7.26 Million
Q4 2021

Feb 14, 2022
BUY
$60.19 - $97.37 $9,269 - $14,994
154 Added 0.15%
101,422 $7.58 Million
Q3 2021

Nov 15, 2021
SELL
$41.02 - $58.65 $96,684 - $138,238
-2,357 Reduced 2.27%
101,268 $5.75 Million
Q2 2021

Aug 16, 2021
SELL
$43.76 - $53.11 $226,501 - $274,897
-5,176 Reduced 4.76%
103,625 $4.56 Million
Q1 2021

May 17, 2021
SELL
$41.69 - $54.95 $91,342 - $120,395
-2,191 Reduced 1.97%
108,801 $5.37 Million
Q4 2020

Feb 12, 2021
SELL
$41.16 - $47.47 $20.4 Million - $23.6 Million
-496,574 Reduced 81.73%
110,992 $4.67 Million
Q3 2020

Nov 16, 2020
BUY
$43.36 - $53.53 $2.13 Million - $2.63 Million
49,060 Added 8.78%
607,566 $27.8 Million
Q2 2020

Aug 14, 2020
BUY
$46.37 - $57.58 $16.2 Million - $20.2 Million
350,218 Added 168.14%
558,506 $28 Million
Q1 2020

May 15, 2020
BUY
$40.22 - $62.0 $4.14 Million - $6.39 Million
103,005 Added 97.84%
208,288 $10.7 Million
Q4 2019

Feb 14, 2020
SELL
$57.95 - $66.61 $157,044 - $180,513
-2,710 Reduced 2.51%
105,283 $6.5 Million
Q3 2019

Nov 14, 2019
SELL
$60.08 - $88.17 $28.3 Million - $41.5 Million
-470,337 Reduced 81.33%
107,993 $6.49 Million
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $5.53 Million - $6.62 Million
68,022 Added 13.33%
578,330 $48.8 Million
Q1 2019

May 15, 2019
BUY
$69.08 - $105.66 $17.8 Million - $27.2 Million
257,840 Added 102.13%
510,308 $48.7 Million
Q4 2018

Feb 14, 2019
BUY
$65.41 - $84.65 $1.88 Million - $2.44 Million
28,790 Added 12.87%
252,468 $17.9 Million
Q3 2018

Nov 14, 2018
BUY
$85.46 - $126.37 $6.5 Million - $9.62 Million
76,092 Added 51.56%
223,678 $19.1 Million
Q2 2018

Aug 14, 2018
BUY
$81.85 - $120.51 $209,536 - $308,505
2,560 Added 1.77%
147,586 $17.1 Million
Q1 2018

May 15, 2018
SELL
$57.91 - $92.15 $466,001 - $741,531
-8,047 Reduced 5.26%
145,026 $11.7 Million
Q4 2017

Feb 12, 2018
BUY
$45.65 - $59.37 $422,536 - $549,528
9,256 Added 6.44%
153,073 $8.98 Million
Q3 2017

Nov 07, 2017
BUY
$37.91 - $46.8 $5.45 Million - $6.73 Million
143,817
143,817 $6.73 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $130M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email